DONALD YEE to Anticoagulants
This is a "connection" page, showing publications DONALD YEE has written about Anticoagulants.
Connection Strength
2.163
-
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
Score: 0.382
-
Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis. J Pediatr. 2015 Sep; 167(3):645-9.
Score: 0.327
-
Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients. Clin Pharmacokinet. 2013 Nov; 52(11):967-80.
Score: 0.291
-
Evaluation of weight-based dosing of unfractionated heparin in obese children. J Pediatr. 2013 Jul; 163(1):150-3.
Score: 0.277
-
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.
Score: 0.269
-
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis. Pediatr Blood Cancer. 2009 Jul; 53(1):100-2.
Score: 0.216
-
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan; 7(1):e18-e27.
Score: 0.110
-
Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
Score: 0.097
-
Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism. Pediatr Blood Cancer. 2017 Nov; 64(11).
Score: 0.093
-
Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities. Blood. 2015 Dec 10; 126(24):2541-7.
Score: 0.083
-
Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patients. Ann Vasc Surg. 2014 Oct; 28(7):1794.e1-7.
Score: 0.019